-
Most Popular
Search Results
240 results for ddic
Qualcomm’s Quiet AI Revolution: Why QCOM Stock Is the Sleeper Hit of 2024
There are plenty of companies in the tech sector growing faster than Qualcomm, but here’s why QCOM stock may be worth a buy.
GTEC Stock: 7 Things to Know About EV Play Greenland Tech as Shares Zoom Higher
Greenland Tech (GTEC) stock is on the rise Thursday after announcing a deal with Fujian South China Heavy Machinery Manufacture.
Amazon.com, Inc. (AMZN) and Comcast Corporation (CMCSA) Strike MAJOR Win-Win Deal
The agreement to sell Comcast packages through Amazon should make investors in both AMZN and CMCSA tune in.
3 ETFs That Hate Apple (AAPL) Right Now – XLK VGT IYW
Gigantic holdings in Apple (AAPL) once held funds like IYW and XLK aloft. Currently, though, they’re cursing Apple’s misfortune.
7 Biotechnology Stocks to Sell Now
For the current week, the overall ratings of seven Biotechnology stocks are worse, according to the Portfolio Grader database. Each of these rates a “D”…
7 Biotechnology Stocks to Sell Now
This week, the ratings of seven Biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
8 Biotechnology Stocks to Sell Now
For the current week, the overall ratings of eight biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a “D” (“sell”)…
7 Biotechnology Stocks to Sell Now
For the current week, the overall ratings of seven biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a “D” (“sell”)…
7 Biotechnology Stocks to Sell Now
This week, the ratings of seven Biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
7 Biotechnology Stocks to Sell Now
The ratings of seven Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F”…
7 Biotechnology Stocks to Sell Now
This week, the ratings of seven Biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
7 Biotechnology Stocks to Sell Now
For the current week, the overall ratings of seven Biotechnology stocks are worse, according to the Portfolio Grader database. Each of these rates a “D”…
7 Biotechnology Stocks to Sell Now
The overall ratings of seven Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…
7 Biotechnology Stocks to Sell Now
The ratings of seven Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F”…
7 Biotechnology Stocks to Sell Now
This week, the overall grades of seven Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…
Emerging Markets’ Outperformance Marches On
Wtih emerging markets continuing their outperformance, we remain bullish long-term on emerging markets but bearish on U.S. banks.
7 Biotechnology Stocks to Sell Now
The overall ratings of seven Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…
8 Biotechnology Stocks to Sell Now
The overall ratings of eight Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…
7 Biotechnology Stocks to Sell Now
This week, the ratings of seven Biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
Look Out Below: Deposit Insurance Is an Unknown Cliffhanger
A government program that insures the entire value of non-interest-bearing deposits is set to expire soon, with more than a trillion dollars hanging in the…
7 Biotechnology Stocks to Sell Now
For the current week, the overall ratings of seven Biotechnology stocks are worse, according to the Portfolio Grader database. Each of these rates a “D”…
7 Biotechnology Stocks to Sell Now
The overall ratings of seven Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…
9 – 10 of 240 results
